Persistent activation of the Akt pathway in head and neck squamous cell carcinoma: a potential target for UCN-01
- PMID: 15217935
- DOI: 10.1158/1078-0432.CCR-03-0249
Persistent activation of the Akt pathway in head and neck squamous cell carcinoma: a potential target for UCN-01
Abstract
Squamous carcinomas of the head and neck (HNSCC) represent the sixth most common cancer among men worldwide and a major cause of morbidity and mortality due to its relatively poor prognosis. As part of ongoing studies addressing the molecular events underlying tumor progression in HNSCC, we have explored the nature of the proliferative pathways in which dysregulation may promote aberrant cell growth in this tumor type. The serine/threonine protein kinase Akt is a downstream target of phosphatidylinositol 3-kinase and a key regulator of normal and cancerous growth and cell fate decisions. Therefore, in this study, we have examined the status of activation of Akt in different stages of squamous cell carcinoma development in mice and in clinical samples from HNSCC patients. By immunohistochemical analysis, using a recently developed phosphorylation state-specific antibody, we demonstrated that Akt activation correlates closely with the progression of mouse skin squamous cell carcinoma. We also observed that activation of Akt is a frequent event in human HNSCC because active Akt can be detected in these tumors with a pattern of expression and localization correlating with the progression of the lesions. In line with these observations, Akt was constitutively activated in a large fraction of HNSCC-derived cell lines. We also provide evidence that the Akt signaling pathway may represent a biologically relevant target for a novel antineoplastic agent, UCN-01, which recently has been shown to be active in cellular and xenograft models for HNSCC at concentrations safely achievable in clinically relevant situations.
Similar articles
-
Mammalian target of rapamycin, a molecular target in squamous cell carcinomas of the head and neck.Cancer Res. 2005 Nov 1;65(21):9953-61. doi: 10.1158/0008-5472.CAN-05-0921. Cancer Res. 2005. PMID: 16267020
-
Antitumor activity of UCN-01 in carcinomas of the head and neck is associated with altered expression of cyclin D3 and p27(KIP1).Clin Cancer Res. 2002 Nov;8(11):3549-60. Clin Cancer Res. 2002. PMID: 12429646
-
Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma.Cancer Res. 2001 Aug 1;61(15):5911-8. Cancer Res. 2001. PMID: 11479233
-
Activation of the PI3-K/AKT pathway and implications for radioresistance mechanisms in head and neck cancer.Lancet Oncol. 2008 Mar;9(3):288-96. doi: 10.1016/S1470-2045(08)70073-1. Lancet Oncol. 2008. PMID: 18308254 Review.
-
Targeting EGFR-PI3K-AKT-mTOR signaling enhances radiosensitivity in head and neck squamous cell carcinoma.Expert Opin Ther Targets. 2015 Jun;19(6):795-805. doi: 10.1517/14728222.2015.1012157. Epub 2015 Feb 5. Expert Opin Ther Targets. 2015. PMID: 25652792 Review.
Cited by
-
AKT3 Is a Novel Regulator of Cancer-Associated Fibroblasts in Head and Neck Squamous Cell Carcinoma.Cancers (Basel). 2021 Mar 11;13(6):1233. doi: 10.3390/cancers13061233. Cancers (Basel). 2021. PMID: 33799788 Free PMC article.
-
Identification of a Novel Proto-oncogenic Network in Head and Neck Squamous Cell Carcinoma.J Natl Cancer Inst. 2015 Jun 10;107(9):djv152. doi: 10.1093/jnci/djv152. Print 2015 Sep. J Natl Cancer Inst. 2015. PMID: 26063791 Free PMC article.
-
MAPK/ERK-dependent translation factor hyperactivation and dysregulated laminin γ2 expression in oral dysplasia and squamous cell carcinoma.Am J Pathol. 2012 Jun;180(6):2462-78. doi: 10.1016/j.ajpath.2012.02.028. Epub 2012 Apr 28. Am J Pathol. 2012. PMID: 22546478 Free PMC article.
-
Molecular cross-talk between the NFkappaB and STAT3 signaling pathways in head and neck squamous cell carcinoma.Neoplasia. 2006 Sep;8(9):733-46. doi: 10.1593/neo.06274. Neoplasia. 2006. PMID: 16984731 Free PMC article.
-
Identification of Molecular Targets and Potential Mechanisms of Yinchen Wuling San Against Head and Neck Squamous Cell Carcinoma by Network Pharmacology and Molecular Docking.Front Genet. 2022 Jul 6;13:914646. doi: 10.3389/fgene.2022.914646. eCollection 2022. Front Genet. 2022. PMID: 35873484 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous